This inventor holds 2 USPTO granted patents and 2 EPO patents. Top assignee: Tel Hashomer Medical Research Infrastructure and Services Ltd.. Active years: 2018-2022.
Location History:
- Tel Aviv, IL (2018)
- Karkur, IL (2022)
Company Filing History:
Years Active: 2018-2022
Title: Efrat Shavit-Stein: Innovator in Glioblastoma Treatment
Introduction
Efrat Shavit-Stein is a prominent inventor based in Tel Aviv, Israel. She has made significant contributions to the field of medical research, particularly in the treatment of malignant gliomas such as glioblastoma. With a total of 2 patents to her name, her work is paving the way for innovative therapeutic approaches.
Latest Patents
Efrat's latest patents include groundbreaking compositions and methods for treating glioblastoma. One patent focuses on a combination of a peptide conjugate derived from the N-terminus of the receptor PAR-1 and the chemotherapeutic agent temozolomide. This innovative approach aims to enhance the efficacy of treatment for patients suffering from this aggressive form of cancer. Another patent involves PAR-1 based therapeutic conjugates, which include a peptide conjugate with a protease-disabling moiety. This invention is directed towards pharmaceutical compositions that can be used to treat diseases associated with excessive PAR-1 activity.
Career Highlights
Efrat Shavit-Stein is affiliated with Tel Hashomer Medical Research Infrastructure and Services Ltd., where she continues to advance her research. Her work is characterized by a commitment to developing effective treatments for complex medical conditions.
Collaborations
Efrat collaborates with Joab Chapman, who is also involved in innovative research within the medical field. Their partnership exemplifies the collaborative spirit that drives advancements in healthcare.
Conclusion
Efrat Shavit-Stein's contributions to glioblastoma treatment highlight her role as a leading inventor in medical research. Her innovative patents and dedication to improving patient outcomes are commendable.